Please assess the completion status of the following clinical trial:

Trial Title: Home Evaluation of Exit Barriers in Wandering

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* veterans age 60 and over with an Alzheimer's-like dementia diagnosis, documented in medical record with International Codes for Diagnosis (ICD-9) codes that include all 290 diagnoses and 331.0~* Mini Mental State Examination (MMSE) 24 or less~* evidence of pre-elopement behaviors operationalized as scoring 1 standard deviation (SD) above mean on any one of the three items that comprise the Revised Algase Wandering Scale-Community Version (RAWS-CV) eloping subscale (#16 - He/she attempts to get outside; #27- He/she stands at the out door wanting to go out; #30- He/she attempts to find or go to familiar locations, even unrealistic ones)~* living in a non-institutional private family home or foster home~* independently ambulatory (with or without canes, walkers or wheelchairs to assist)~* living within a 60-mile radius of the James A. Haley Veterans Administration Medical Center (VAMC), Tampa, Florida~* living with a caregiver (CG) who is willing and able to serve as a study partner and provide informant reports, and who intends to be with the PDW for three months (allowing for being away for seven days or less during the three-month study period)~* English speaking.~Exclusion Criteria:~* living in a nursing home, group home or assisted living facility at point of entry (foster homes allowed)~* previous exposure to any visual exit barrier for wandering management~* no live-in CG~* bilaterally deaf or blind~* currently taking anti-psychotic medications~* current use of any visual exit barrier on any main exit doorway. CG will be allowed to use other wandering management interventions that are not specific to the exit doorways. For example, they may use a stop sign at the entrance to the kitchen, but may not use a stop sign on an experimentally monitored door.

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Door Cover/Floor Cover (Type: EXPERIMENTAL): Baseline One (14 days), First Intervention (14 days), Baseline Two (14 days), Second Intervention (14 days)

Based on this trial design, predict the completion outcome and termination type (if applicable).